<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>MOLECULAR AND CELLULAR BIOLOGY, Feb. 1988, p. 843-853                                                                   Vol. 8, No. 2 <br /> 0270-7306/88/020843-11$02.00/0 <br /> Copyright X 1988, American Society Microbiology <br />  <br />  <br />       DNA Sequence, Structure, Tyrosine Kinase Activity the <br />        Drosophila melanogaster Abelson Proto-Oncogene Homolog <br />       MARK J. HENKEMEYER, RANDY L. BENNETT, FRANK B. GERTLER, AND F. MICHAEL HOFFMANN* <br />              McArdle Laboratory Cancer Research, University Wisconsin, Madison, Wisconsin 53706 <br />                                        Received 30 September 1987/Accepted 16 November 1987 <br />  <br />              We report molecular characterization Drosophila melanogaster Abelson gene (abl), gene which <br />            recessive loss-of-function mutations result lethality pupal stage development. This essential gene <br />            consists 10 exons extending 26 kilobase pairs genomic DNA. The DNA sequence encodes protein <br />            1,520 amino acids strong sequence similarit human c-abl proto-oncogene beginning type <br />            lb 5&apos; exon extending region essential tyrosine kinase activity. When tyrosine kinase <br />            homologous region expressed Escherichia coli, phosphorylation proteins tyrosine residues was <br />            observed antiphosphotyrosine antibody. These results abl gene highly conserved <br />            evolution encodes functional tyrosine protein kinase required Drosophila development. <br />  <br />    Protein tyrosine kinases identified viral          kinase published tyrosine kinase <br /> transforming proteins acutely oncogenic retroviruses (17).           sequences (15). The Drosophila sequence called Dash, <br /> It determined sequences encoding pro-                Drosophila Abelson-src homologous. In view more <br /> teins transduced cellular sequences. Two classes              extensive similarity Abelson gene reported in <br /> of protein tyrosine kinases described: cyto-              keeping convention three-letter <span id='am-4' about='Thesaurus:code' typeof='owl:Thing'>code</span> for <br /> plasmic tyrosine kinases src, abl, yes, fgr,               Drosophila genes, suggest Drosophila gene be <br /> fps-fes members membrane-spanning growth                    called abl. <br /> factor receptor tyrosine kinases, including erbB, fms, ros,               We identified mutations Drosophila abl gene <br /> and neu (16). Other cell surface receptors encoding tyrosine            failure complement chromosomal deletions that <br /> kinase activity include receptors insulin platelet-         overlap abl transcription <span id='am-1' about='Thesaurus:Unit' typeof='owl:Thing'>unit</span> rescue the <br /> derived growth factor (51, 55).                                         mutant phenotypes cloned abl DNA transgenic flies <br />    The Abelson (abl) tyrosine kinase proto-oncogene ex-              (13a). As continuation analysis gene, the <br /> pressed wide variety mammalian cells (54). It          genomic structure determined nucleotide level. In <br /> alternate 5&apos; exons amino termini mouse (1)               addition having sequence similarity mammalian abl <br /> two alternate 5&apos; exons amino termini humans (45).                genes, Drosophila gene encodes functional protein <br /> The function alternate processing 5&apos; ends          kinase capable phosphorylating proteins tyrosine res- <br /> genes known; however, exons                 idues. <br /> replaced Abelson proto-oncogene activated a <br /> transforming oncogene Abelson murine leukemia                                   MATERIALS AND METHODS <br /> retrovirus, human chronic myelogenous leukemia (54),                    DNAs. XDabl-1, Charon 4 clone Canton S flies, was <br /> and human acute lymphocytic leukemias (9). Once                 isolated low-stringency hybridizations v-abl <br /> activated, altered abl proteins exhibit elevated tyrosine               probe (14). XDashor2 isolated library (provided <br /> kinase activity (7), shown essential           J. Pustell, Harvard University) Oregon R fly DNA in <br /> the transforming activity Abelson murine leuke-             EMB3L 4 vector. X4.8 X4.8.5 Charon 4, clones <span id='am-3' about='protege:FROM' typeof='owl:Thing'>from</span> <br /> mia virus (32).                                                         library Canton S DNA, isolated McKeown et al. <br />    Several Drosophila melanogaster genes shown                (27) chromosomal walk originating abl. Cloned <br /> <span id='am-7' about='protege:TO' typeof='owl:Thing'>to</span> extensive sequence similarity mammalian              genomic DNAs subcloned pSDL12 -13 (23) or <br /> avian proto-oncogenes (44). The Drosophila homologs in-                 pTZ18r -19r (Pharmacia, Inc., Piscataway, N.J.) vectors, <br /> clude members tyrosine kinase family (11, 14, 15, 47),           overlapping deletions obtained using either <br /> the ras family (30, 41), epidermal growth factor receptor            DNaseI (21) T4 DNA polymerase (6). <br /> homolog (25), myb homolog (18). The Drosophila                       Drosophila cDNAs isolated embryonic and <br /> genes sevenless (13) wingless (36) originally stud-            pupal XGT10 cDNA libraries (31). The libraries probed <br /> ied mutant phenotypes; subsequently              vitro-synthesized RNA derived subcloned <br /> amino acid sequences similar to, respec-               genomic fragments. Positives plaque purified used <br /> tively, tyrosine kinase int-i proto-oncogene sequences.             probe blots cloned DNA spanning Drosophila abl <br /> The levels spatial distributions transcripts              region. The cDNA inserts subcloned pTZ18r or <br /> number Drosophila genes suggest expres-               pTZ19r. <br />  sion developmentally controlled associated               Sequence analysis. The production single-stranded bac- <br /> proliferating cells terminally differentiated tissues          teriophage induced superinfection plasmid-con- <br /> (13, 36, 40, 42, 46, 49).                                               taining bacteria helper phage M13ko7 (Pharmacia). <br />    We reported Drosophila amino acid sequence               Phage DNA purified subjected dideoxynucleotide <br /> is similar kinase domain Abelson tyrosine            sequencing (39) [355]dATP (2). The M13 reverse primer <br />                                                                         (New England BioLabs, Inc., Beverly, Mass.) custom- <br />   * <br />       Corresponding author.                                             synthesized oligomers (University Wisconsin Biotechnol- <br />                                                                   843 <br />  844    HENKEMEYER ET AL.                                                                                    MOL. CELL. BIOL. <br />  <br /> ogy Center) used prime sequencing reactions.         mid-log phase (A6. = 0.6 0.7), fusion protein synthe- <br /> Compressed regions resolved replacing deoxygua-          sis induced adding isopropyl-,3-D-thiogalactopy- <br /> nosine deoxyinosine reactions (28). Sequence         ranoside final concentration 1 mM. After 2-h <br /> reactions separated 4% acrylamide short (45 35        incubation, 1-ml samples cultures centrifuged, <br /> cm) 2% acrylamide long (115 35 cm) gels containing 7       bacterial pellets suspended 100 ,ul 2x <br /> M urea 0.5x TBE (lx TBE 89 mM Tris, 89 mM boric           sodium dodecyl sulfate sample buffer (20) boiled 5 <br /> acid, 2 mM EDTA [pH 8.0]). Gels dried          min. A 20-pdl sample loaded lane 10% <br /> of glass plates autoradiography (10). Analysis     polyacrylamide gel. After electrophoresis, proteins were <br /> the sequence data accomplished pro-            electrotransferred nitrocellulose paper (0.45-pum pore <br /> grams (8, 34, 35).                                               size; Schleicher &amp; Schuell, Inc., Keene, N.H.). The electro- <br />    Primer extension. Total embryonic RNA isolated       transfer buffer Towbin et al. (50). Efficiency of <br /> 0 17-h-old embryos (5). A 20-pmol sample gel-purified    protein transfer checked staining nitrocellulose <br /> oligomer (5&apos;-CATTGCCAGTGGGTGGTTGG-3&apos;) la-                    filters Ponceau S stain (Sigma Chemical Co., St. Louis, <br /> beled polynucleotide kinase 0.5 mCi [32P]ATP        Mo.). Blots blocked 2 h room temperature <br /> (3,000 Ci/mmol; Amersham Corp., Arlington Heights, Ill.)         1% Carnation nonfat dry milk phosphate-buffered <br /> (26). Unincorporated nucleotides removed             saline-Tween (PBS-T; 10 mM KH2PO4, 150 mM NaCl, <br /> successive ethanol precipitations 2 M ammonium acetate.       0.05% Tween 20 [pH 7.2]). Blots rinsed time with <br /> A 1-pd sample 5x primer extension buffer (250 mM Tris         PBS-T incubated 0.3 p.g antiphosphotyro- <br /> [pH 8.3], 250 mM KCl, 50 mM MgCl2, 200 mM dithiothrei-           sine (PTyr) antibody ml (52) PBS-T containing 3% <br /> tol) added 0.3 pmol dried kinased primer          fraction V bovine serum albumin (Miles Scientific, Div. <br /> siliconized Eppendorf tube. A 100-,ug sample (4 ,ul) total    Miles Laboratories, Inc., Naperville, Ill.) 3 h room <br /> embryonic RNA tRNA (as control) added               temperature. After 10-min washes 1% dry milk in <br /> gently mixed. The mixture pipetted drawn-out          PBS-T, blots incubated anti-rabbit immuno- <br /> siliconized 20-pd capillary pipette. The pipette sealed      globulin G antibodies conjugated alkaline phosphatase <br /> over flame placed boiling-water bath 2 min. The   (Sigma) 1:1,000 dilution 1% dry milk-PBS-T 1 h. <br /> pipette immediately transferred 60&#194;&#176;C water         Blots washed developed Nitro Blue <br /> bath. After 1-h hybridization, mixture quickly         Tetrazolium bromochloroindolylphosphate 0.1 M <br /> expelled 5 pR1 reverse transcriptase mix (1 x primer     Tris buffer (pH 9.5) (Kirkegaard Perry Laboratories, <br /> extension buffer, 10 units RNasin, 2 mM deoxynu-         Gaithersburg, Md.) detect immunoreactive proteins. <br /> cleoside triphosphate, 40 U Moloney murine leukemia <br /> virus reverse transcriptase) incubated 37&#194;&#176;C 30 min.                             RESULTS <br /> Fresh reverse transcriptase mix (5 ,lI) added then <br /> incubated 30 min. Preboiled RNase A (10 ,ul        Isolation genomic cDNA clones. The recombi- <br /> 5-mg/ml stock) added incubated 37&#194;&#176;C 15 min.       nant clone Drosophila abl gene (ADabl-1) isolated <br /> After extraction phenol-chloroform, mixture      probing Drosophila genomic DNA libraries low hybrid- <br /> ethanol precipitated 2 M ammonium acetate. The exten-         ization stringency v-abl probe Abelson murine <br /> sion products suspended formamide-containing brom-       leukemia virus (14). Overlapping clones isolated with <br /> phenol blue-xylene cyanol, boiled 3 min, iced,      probes derived isolated fragments subclones of <br /> resolved 8% acrylamide sequencing gel. A DNA               ADabl-1. McKeown et al. (27) used Drosophila abl DNA <br /> sequence reaction kinased primer          probes initiate chromosomal walk Drosophila <br /> loaded gel provide size standards. Gels           gene transformer, generously provided with <br /> exposed film Cronex Lightning-Plus intensifying      clones X4.8 X4.8.5 (Fig. 1). <br /> screens.                                                            Portions genomic DNA similar v-abl <br />    Construction bacterial lacZ-abl fusion genes. Two por-     probe sequenced contain open reading <br /> tions abl gene cloned pUR series         frame encoded putative protein product extensive <br /> bacterial expression vectors (37). pURABLkin con-            amino acid similarity v-abl protein (15). This same <br /> structed digesting abl cDNA P1 PstI        region genomic DNA detected RNA products on <br /> PvuII gel isolating 1.4-kilobase fragment. The vec-      Northern (RNA) blots ranging size 5.5 6.0 <br /> tor, pUR291, cut HindIII, flush end           kilobases (22, 49). Fragments genomic DNA were <br /> created Klenow fragment DNA polymerase I.            used screen cDNA libraries, number cDNA <br /> The vector cut PstI, PstI-PvuII abl        clones isolated embryonic pupal libraries <br /> fragment ligated vector. pURABLcarb             (Fig. 2). The cDNAs localized genomic map by <br /> constructed digesting abl cDNA L PstI, isolating     restriction endonuclease mapping Southern blot analysis <br /> the 0.9-kilobase fragment, ligating vector       cloned genomic DNA (data shown). <br /> pUR290, previously digested PstI.               DNA sequence exonic structure abl. The Drosophila <br /> Plasmids in-frame fusions detected appear-      abl genomic cDNA clones sequenced sub- <br /> ance novel 170- 155-kilodalton proteins Coomassie      cloning DNAs appropriate vectors creating a <br /> blue-stained polyacrylamide gels lysates induced         series overlapping deletions. The locations se- <br /> Escherichia coli (CSH26) cultures containing pURABLkin           quenced fragments shown Fig. 2. In cases, a <br /> and pURABLcarb, respectively.                                    synthetic oligonucleotide primer complementary end <br />    Immunoblots. Overnight cultures E. coli containing         sequenced region used extend sequence fill <br /> pUR290, pURABLkin, pURABLcarb grown L                gap (arrows beginning dots Fig. 2). The gaps <br /> broth containing 50 jig ampicillin ml 50 ,ug       remaining sequence data internal introns 1 and <br /> streptomycin ml (CSH26 carries streptomycin resis-         2. <br /> tance gene). These overnight cultures diluted 1:100       The composite sequence genomic cDNA clones <br /> L broth plus ampicillin streptomycin grown        shown Fig. 3. The sequence includes 10,343 <span id='am-8' about='xsp:base' typeof='owl:Thing'>base</span> pairs <br />                                                                                                              _ <br /> VOL. 8, 1988                                                                                                  D. MELANOGASTER ABELSON TYROSINE KINASE                                                                 845 <br />  <br />                           .Cenrtomere <br />  <br />                                                                                         *   *                                                         * <br />  <br />                       H     H BE                   E H               H       SBH S H E                       E                          ES        E   H           SW~iB <br />                                                                                                                                                                      B    SB            HE         E     S SE <br />                       II        I   I              I I                                 II I                  ~~I            I                     I       I <br />                                                                                                                                                                       I       fi        lEII <br />  <br />                                                                                          X 4.8 <br />                                             X 4.8.5                                                                                      X Dab 1 <br />  <br />                                                                                                                                                                     XA Dashor77 <br />  <br />  <br />                                                l               l              l                  l                     l                      I                                    II <br />                 152       148       144      140      136        132      128    124     120        116       112      108 Kb <br />    FIG. 1. Restriction map Drosophila abl homolog. Four overlapping phage inserts containing abl sequences used study are <br /> shown map. Restriction enzyme sites located map BamHI (B), EcoRI (E), HindlIl (H), Sall (S). Restriction site <br /> polymorphisms Ki,roe,pP chromosome background indicated asterisks. A polymorphism Canton S <br /> isolates (XDabl-1, X4.8, X4.8.5) Oregon R isolate (XDashor7) shown 300-bp insertion XDashor7. Hatched boxes <br /> indicate genomic DNA sequenced analysis. Direction transcription left right. Coordinate zero scale the <br /> position In(3LR)st-a27 breakpoint scarlet locus (27). The chromosome arm (3L) reverse orientation centromere <br /> to left telomere right. Kb, Kilobases. <br />  <br />  <br /> (bp) DNA discontinuity (arrows)                                                         act Goldberg-Hogness TATA box. There a <br /> two introns. Including introns, abl transcrip-                                                           CAAAT sequence -95. Some repeated sequences exist in <br /> tion <span id='am-2' about='Thesaurus:Unit' typeof='owl:Thing'>unit</span> spans 26 kilobase pairs genomic DNA. The                                                              putative promoter including seven copies AAAGC <br /> assignment position introns, exception                                                          repeat regions alternating purine-pyrimidine <br /> the introns highly conserved kinase domain,                                                               repeats. The role sequences function the <br /> were determined sequencing exon junctions                                                             promoter known. There open reading frame <br /> cDNA clones. Primer extension embryonic RNA                                                                     beginning exon 1 extending exon 10; encodes a <br /> used determine transcription initiation point (Fig. 4).                                                         protein 1,520 amino acids. The initiation codon position <br /> The cap site (position + 1 DNA sequence) 39 bp 5&apos;                                                            +97 preceded in-frame stop codons positions <br /> from start longest cDNA, P1 (Fig. 3). The                                                                   +7, -9, -12, -15, -18. <br /> sequence TAATAA present 25 bp 5&apos; cap site                                                                  We compared sizes abl exons derived the <br />  <br />     ,oromwe <br />                                             IKb <br />  <br />     Gon DNA-.                                                                               0-04            4I-            4-                 *4 <br />                                                                                                                                                -      4       -           -             -    4w         -. <br />                                                                                                                                                                                                         4       4-U <br />  <br />                                                                                              _   .__* <br />  <br /> H                     S         B       H             S                  P                                         _                _ <br /> t                                                         a-etL-.        L <br /> .                     ,     _           I             I   13-SKh <br />                                                           I 0.0 VW                                                          &apos;WI-9- <br />  <br />  <br />  <br />  <br />                                    hsgn dDNAFtnN <br />                             oposke ful                                                                                                  s                                                         -V <br />                             DNAmmd:                                               5. <br />                                                                      P1                                 .              .        .       ... <br />  <br />  <br />  <br />  <br />                                                                      PM <br />                                                                                                                                                                                                   *s <br />                                                                      G                                                                                                                             3. <br />                                                                                                                                                                                    =~~~~~ <br />                                                                      d)ASH 1.5 <br />   FIG. 2. Sequencing strategy, location cDNAs, exon organization Drosophila abl. The arrows DNA map indicate the <br /> regions sequenced. Single-stranded phage DNA sequenced annealing standard M13 reverse primer (arrow) or <br /> custom-synthesized primers (indicated dot) purchased University Wisconsin Biotechnology Center. Open boxes represent <br /> the 10 abl exons, lines represent introns 5&apos; 3&apos; nontranscribed sequences. The map discontinuous intron 1, totals <br /> 14.5 kilobases (kb) <span id='am-6' about='xsp:length' typeof='owl:Thing'>length</span>. The 5&apos; 3&apos; ends shown composite full-length mRNA, positions translation initiation <br /> and termination codons. Below composite mRNA maps cDNA clones isolated pupal (P1 P4Cl) embryonic (L, G, <br /> and cDash 1.5) libraries. Regions sequenced cDNA clones indicated respective isolates. The 5&apos; P1 indicates <br /> that cDNA contains 5&apos; untranslated sequences, 3&apos; L G indicates poly(A) tails present cDNAs. <br /> All splice junctions confirmed sequencing cDNAs introns 3, 4, 5. <br />  846   HENKEMEYER ET AL.                                                                                                                                          McDL. CELL. BIOL. <br />                                    - 7 3SccscTJiTcaca <br />                                           CGG?GtGA?A             ATT?A??TCAA?A?Cr.A?ACGC?ca?CGTATCCTGCCAAG?aSATGc???AAACGACCccaAGCc G?CocACACGA?CAAGT?GGA??CC            -622 <br />        AA??CGA?UsCCTCC AuTOC?GC?GACAAC^ACTACAGA?GAGTACCAI?CCAlCCACCTCAACsaCAGAGCCTATA? CC?A?ACAaJUGCGAACr.TA?ATCCA???GCCC??CAGGGTCAGCC?GCGGATCAATT^AACCGTAKA <br />                                                                                                                                                                          -472 <br />        AAAACCAGGCAGCSAGAACCUACAGACCAAGGCAliGCCAGACaG         C C    AACSCC^TTCTCAGGCTGTTTTGAGACCCSCCCTCCaCAT GTCACCCAGCCCCTCCCACCTCGCAAGAAG TTTGCCGACAC                  -322 <br />        AACATTTTACCAACATGCTGCAAATTCCAATCATCCTGACGGCCACTAGACAACAAACA?ATAA?TCCCAACCC?CCTTT?CCTCCGTCGTCT?CTTCTGTGTGATGCG?TTCCTCCATCTTTTTTGTCTACTCCAA                         -172 <br />        AACG       CC            TTOCCC AATTAATCTCAAATCAL TAaAAGCAACOWAAATAAT?WAATasa       cAAGGCC        cAAACTTGAAGAAAACAAaAAAACAAAGCAAATAATA                          -22 <br />  <br />                                                                     P1 eDNA START                                                   1 <br />                                                                    *+                                                             MstGlyAlaG1nG1nGlyLysaspArqGlyAlaM <br />        AGTAGTOATAAGCGTaacAAGCTAGAGC                  wu-rcc- <br />                                                         TTTCTGCGCAAGAGCGAAAAACCACCCAACCCACCCACTGGCAAATGGGCTCACCCAGOrCAAGCAGGGCGCCC                                       130 <br />  <br />        sS*rGlyGlyGlyGlyS*rGlyAalProV&amp; lS rCys I ldlyL uS rS-rS rProValAl^SorV lS-rProH1 *Cy*II*S*rS*rSerSerGlyVa IS rS rAl ProL uGlyGlyGlySerThrL uArgGlyS-rArg I <br />        ACT        _SC            TCA GCTGC                = AGCAGCCC:AGTCTCCCS   TCSCtCSCSCACTOCATCCAGTCOCAGCGTCGAGCACGCCCCCCTCGGCGGGCTCCACGCTCCGTGGCTCCCGCA             280 <br />                                                                                                                                                                 111 <br />        l-LysS rSerS rS-rClyV Il&amp;lS rGlyS rG1yS-rGlyGlyGlyClyGlyGlyS rGlySerGlyL uS rGInArgS rGlyGlyHlsLysa pAleakrCysa nProThrV lGlyLouAsnllePh ShrGluH1sksnG <br />        TCAAGTCCTCGTCCTmcCGTG:cACCCAGGCAGCOGATC=WGGCG <br />                                                 cSAsSToeaTCCG                  TGACCTa .TGCGGcACASCAAGTGCAGTCACCCACC          GTGGGTCTcCATACTTTCACCGAGCATAACG            430 <br />                                                                                                   14.S XS <br />        GTAAGTTCC?GATTTCGGAACa           CASCCATGCCTAGTAAAGCAAGCT     maCCCaaaC            C     CCTOCTGAAASTGCACTSaCTCTTCATGATATACCAGATTACCATCGGCTACAATTG                50 <br />  <br />  <br />                                                      113                                              129 <br />                                                    ly?hrLysHlsS.rS.rPbeArqGlyNlsProClyLy&amp;Tyrgils5tkanL.uC <br />        CCTCTCACC&apos;CAAJATCTTTCTGTTSTTCTGTTCSCTTCAGTCCACCACC        CCI _ 1=    ACTTlCTlACTGS^ASACCCTTJ <br />                                                                                                    T GTCGCATGAG                                                          730 <br />                   1.2 U <br />  <br />        GsTTCAssTaccaaTaCssTAACTAscTaGax~TACTTTcoTaAcTAGarTACASTAATCOSSWUTTTCTLTACCTTGAGCT                   _         Toc <br />        TACCC_     eTC TCTU7CT_SC7CC_TC <br />                                                                                                                                                                         1030 <br />        AGClCC = C^TSSTCTA&amp;TTTTATSlCCO    ST^^TOCAT^^TT _C                    _TCC                                                                                        1130 <br />        TTGCT?TCTCCTACTACCT CAAAAMACGATTTOCAAAATCTC?AkT              -    G                      ATA^AAACACGA                                                             1330 <br />                                                                                                                                                                          1480 <br />                                                                                                                 131 <br />                                                                                                             luAlaL.uLouGlnSerkrgProLOuProHisIl?ProAlaGlyS.rThrarqPr <br />                                                                                                                                                                          1630 <br />  <br />  <br />  <br />                                                                                                                                                                         1710 <br />  <br />  <br />                                                                                                                                                                         1930 <br />                                         ,V-ABL <br />  <br />        rooL Pb yLsrarlPhl^VluThrClnGlnAlClysPhlnATpSrLCulyCCluLyuL uOlNnClySerVSoroL <br />                                                                                   u      sluGllyHiolyL-r ullTThrS rVoL*u lu?yrPkl HProLarqInAbsnLyPrThraulPhurL <br />                 TCTlCGT                                                                              TCC7C7CCCaATACCGTCTTTCSCOCSCCGC1_as 2060 <br />                                                                          ACCCC7CCTCCOACCTAGCS;CTTCOC== <br />  <br />  <br />                                           309                                                                               311 <br />        *PSrolProGlluurAspGluTpProluL ubVleCskrkpluSyrAtph LysiLysCulyGlyGlyAClnLTuSrGLy <br />        rGluS.rSerProGlyGInArqS.r1l.o.rL.ukr                                                uV    lTyrGluGlnValTrpLyL uSyrGSyA^snThrVarlAlVly&amp;lThrpLyCluAspH1*Sra <br />                                                                                                                       gTyEG1uG1yAXYValTyrHL*TyPArgI1000rGluaspP <br />                                                                                                                                                                         2230 <br />  <br />  <br />  <br />  <br />          pSryysV lClyaThrrpV lur roroPhS Tyr <br />                                           lfPoIL ThrGl CuLMSHri*GysnrSrpSyrH1plyProLI1-rS rAr&amp;GAnlykrgGluThrL^uLuS <br />                                                                                                                  rSAlCVylAlaLonuouySrPbtAL uVlnlArager                  2380 <br />                                                                                                                                   AT? <br />        CCCTATC^AGGTCTCTOCACCAGAGCCC?CCACCT^TCTSACATCCCCGSAGTTTCCATTCGCTOTACCC7 <br />                      sr T?K                                                     TCGJUOCCCCTCSTA;SCCUCUCCCTCSCCTCCCTC <br />  <br />  <br />                                                                                                                                                                         2530 <br />        rClyuStrTyrProCluClnArgSArnTySrLleuAr      gLTyrGUAnyaeVllAsAnyLeVlyVIA&amp;sPoGyo <br />                                                                                    W LouCltArgAsphsThrTlyrThrAl-HSArluaGyAP <br />                                                                                448 <br />        *tAlaLeuLyAskpPh.L.uGluGluAlaAlaIllNstLy.GluNstLysHbgProAsnL.uValGlnL.uxlle <br />        LyA phrlyyVlPhy pVThrAlnCroluAlyL,&quot;ayPhSrksLyuAl^ClrTuLyuV erHsp1*lrp laProl luly01 <br />                                                                                         CuouplyuIlokbThrTroLeLy <br />                                                                                                              uSyrPolProTyr rolalanLmu?hTrV lPh P?ro         2680 <br />        AATCCCGTAATGGACCACGAGGG7GC7C?C7WA?TACCAC:mRtATCsTaacGC__                                        ACTATGAAG                                    CSSSO^;cccctC <br />                    450 <br />  <br />                                                                                                                                                                         2830 <br />                                                                                                                                               MAJOR <br />  <br />              GuPoluSPSroAluShrpluAl ClGuysAGTnhrAsnAl-ttALsnAlThSLyLrAyCylyCrSrSrlnPSyrTrClCu SerClyVAI ThrGlyGyaGlyAOlAThrThrThrhrlAlaVlyShrGLyuy Clag       pSertlr <br />        CJGUTAGCTACCGACATCGGCGCACTACATCACGMCGACCACGCCACOCACGCTGACGCT? <br />        sCOCATGCACCGAGTscccCGGTasGAAAAcaGGAWCCacacAGsT                  GASCAATt- <br />                                                                   CCOGC?CT <br />                                                                      CTCCCCCCA7AC OCCC AA CAC00cMcG       cGccc?cAcc7 <br />                                                                                            ACCAGACGCGCCTAGCGC?CGCTCCTACC?                                               2960 <br />  <br />  <br />        *rAlLThLyApPh <br />                    LeuCeLouThrProGlIntVltLy CtelySLysuProGAlGnAVlGlL uThI1 C            afiHmnsPoisIGnIk&amp;erhPoeSr                                                       3130 <br />        SCGOCAC7CCIC7C <br />              CSaACCGCCCCSAaAGTCCACACGCASACTiGAAAGGG?TT                                          AACGAtCCACCOACaSSCATAGCACCATGCAAGGCCASGTAASCCTTTGCJCT <br />  <br />                  lyv lsthragGluPoPuThetrI-lyerhSbr?luhdLyLtS rThrheSernLuLpPbyLyuaGlys ralGiCNArgkrluhrTr A nLysGInGlyL uysGInAlaPrk&amp;roproLysAlSrq                      3280 <br />        AC?CSAGST?TCA?GCCA?TCTTCAGACCGATCCACSTCTCCACCCAACTASC_ACTTCSSCC7CAGCC                                                                                            3430 <br />                                                                                                                                                                         3580 <br />                                                                                                                                         734 <br />  <br />                                                                                                                                                                         3730 <br />                                                                                                     ATTATCGATGAATAA7CTC7CCTCGATG?aCG <br />        ACAGSTAAGCCSACACACTCTCTTATGG?GGA?CGAATCAGiC?T?SCACAA?GTGTAl ==AASC7CATTAGGCAAAtAGSCCAGAhSCCSCCGAGG <br />  <br />  <br />                                                    ~~ <br />                                                  73&#194;&#163;~ <br />                                                     ~~ ~                     ~~~~~~~~~~~~~~~~~3                                                                         3660 <br />  <br />  <br />  <br />                                                                                                                                                                         4030 <br />        774                                                                                                                                        77&#194;&#163; <br />        ThrSA                                                                                                                                     rL.uL*uSerS*rSerArq <br />                                                                                                                                                                         4130 <br />                                                                                       604 <br />  <br />            GACTCCACTTATCGCGAGGAGGCATCCACCCAACGCCACATOCCATTTCATCGCGACCTCCAGCACGAATGGTAAtCACAAATTAAATCCAACTATTTCAGCCAACCCTCTCACAAGtAACATTCAWAAAATTCCAACCCACCAT                            4330 <br />            ACACACCAAATACGTACACAACAACAACAACACAACAGTCCGTAACACAACaJIAACAAATASGTACCATTGTCAG?CACAACAACCAACACTCAACAACAGCAAACAAACAACaACGTATTCCATTAAGA&amp;ATCGTCCTCCTCCAGTAGT                      4460 <br />            TTTCSTTACGACATCC?A-xiCGAGTATT??G?AAiCCGGAGTCCATAGCGCAAxATCTCCTATTAnASAJACTTA ssGxC.iTSGTTATTGSTTTGTTACT?TTTTTTAATTGTAATTGGTTTGTTACTACTTACAT <br />                                                                                           AST                                                                                           4630 <br />            AJiGTTTCTGCATTATTGGTTGTTCATTGTGGAAGATCTCTTCATAGC KTTCaSCCGOCGGTSxATTCAILATTCAGaaTTACSAATTCaAATATT STCGATGSCTTTCCT CTT &amp;&amp;ass&amp;LCTCSCAGATCTCTAG                                 4780 <br />            CATTAACATTTTCATTTGATGTTTCTCTAACCATCCCASTTCCACTATTTTGCGT.G&amp;GTTATATTGCTTTCCASSTSCTanATTCSSTT     TTOCC   TATA   CGTGTTTTTtATTTAGTAATTATTTTAACT                                 4930 <br />            ATCATATGGTTTATATCCTTGAAAGTCGTSATTCTTTAATATACSC CTCGSSaAS                                             GSGSCTGTAATTCGATGGATCCTA?ATTACCCAAAiATAGGATGGACTTTAAGAA <br />                                                                             CTTATCTTGTGSSATCTTAGTTATTTAACCT TGTAGC                                                                      5060 <br />            TATTAAAACTCAATTTAGAAATCAATGaAAACACTASTGTAATGCATCCTTTCAGTSTAACCAG;ATATSTCCiUICAACCTCATTTAATTATAAGTTGATAATTTGGTGTTTTCTAGSTTTTACTCICTCGCAAACATCAACGCACAC                        5230 <br />                               sAACCCATACCCAATccsscaGssGsATGACTAATa <br />            ATCCCAAGCTGTAGTTcAacccG                                                    AG&amp;TCGGTACTCTTATAAACTCAGTTTTTCAsACCAGATATAARAATTATkTCAGTmatascaGsC?AGATAG?                        5380 <br />  <br />  <br />                                                                                                                                                        lyL*uAlaArgAspIleA nSerLeuTh <br />            TTTCCCATCACTGACCATTAATACCACC CACCATCAAAKGT*                      asCAc^TTGAT ITG              CACTGSTTTAC <br />                                                                                          _ACSCASSGACASCACGG <br />  <br />  <br />            rGInArcj?yrkspSerGiu?hrkspProAlaAlakspProaspThrksphl&amp;ThrGlyAspSerLouGluGInSerL*uSerGInValIlekl&amp;kl&amp;ProValThrksaLysfttGlnHisSerL*uHisSerGlyGlyGlyGlyGlyGl <br />            GCAGCGG?ACGA??CCGAkACAC.k?CCGGCAGCCGkCccGGWAC              12r.&apos;r.&apos;rf-,--AG?C?GGAGCAGACTCTGAOCC                                                                              5630 <br />  <br />  <br />            yIleGlyProArg3orSerGInGlnHisSerS*rPhoLyskrgProThrGlyTbrProV&amp;lN*tGlyksnkrgGlylAmGluThrkrgGlnSerLyakrq&quot;rGlnL*uHisSerGInAlaProGlyProGlyProProS*rThrGlnpr <br />            AATAGGTCC                                                                                                                                               Cr-ICCATCAACTCAACC   5830 <br />  <br />  <br />            oHisHisGlyksnkenGlyV&amp;IV&amp;I?hr2orklaRisProIle?hrValGlykl&amp;LeukxpV&amp;lnotksnValLy*GlnValValksnkrqTyrC.lyThrLouProLyoGlykl&amp;krglleGlykl&amp;TyrLou&quot;pSerLouGluAspSe <br />            GCkTCkTGGCkAC                                    TGWTGCOC                                                                                   TG=                        AG    5960 <br />  <br />  <br />  <br />           CAG                               TGCTCCT                                 GCCTccr.0c                                                        TCkGGAWAACTCGTCGGGCGGAGTGAC       6130 <br />  <br />  <br />  <br />           CA?GCAAAAC         ?CC                                                                        ICCxICI&quot;-&quot;&apos;-mCP-MMCGGlr?CCAG?AGC?CACCCAAGCGGAG?GCC?CGGGAGTGOCwMAGGAG?CCA        6280 <br />  <br />  <br />           nProAlaL.ouAlaAanLouGluPhoProProProProLeukspLeuProPr*ProProGluGluPbeGluGlyGlyProProProProProProAlaProGluSerAI&amp;V&amp;lGlnklall*GlnGlnHisLeuHisAl&amp;GlnLouProks <br />           GCCAGCTCTGOCCAACCTTGAG                                                                                   AA.A.AAA IIAA                   TCCAGCAGCACTTGCATOCCCAGCTGCCAAA      6430 <br />  <br />  <br />           nAsnGlyksnIleSerAsnGlykanGlyThrksnksnksnk*pSerSergi&quot;snAspValSerAmnlIsAI&amp;ProSerValGloGluklaSerSerArgPhWlyValSorLsuArgLysArqGluProSerThrAsp$*rCyaSerSe <br />           CAATGGCAACATTACCAATGGAAACGGAACAAACAACAACGACA(;CAGCCACAACGATGTTAOCAACAT                                                                                           TGCAGCTC     6580 <br />  <br />  <br />           rLAuGlySerProProGlukopLouLys4luLyaLouIleTbrGlulleLy&quot;I&amp;Al&amp;GlyLysAapTbrJa&amp;Pr*AlaSerHisL*uAlaAanGlySerGlyIl*Al&amp;ValValAspProV&amp;IS*rLouLauValThrGluL*uAlaGI <br />           GCTGGGCAGTCC                   AAAAGCT                             MAGGAT     TOCTCCGGCCTCACATCTGGCCAACGGCTMOCCATCGCTGTCGTGGACCCCGTCTCCCTGCTTGTCACCGAACTAGCCGA                6730 <br />  <br />  <br />            uS*rN*tksnL*uProLysProlProlProGinGinGinGinLysLouThrAonGlyAsnSerThrGlySerGlyPhoLysklaGInL*uLyaLysValGluProLysLysfttSorkl&amp;ProMetProLyskrqThrklaksnThrll*Ii <br />            GAOCkTGkACCTGCC    DPCeCCOPrar                                                                      kAGAAAG                               khTGCCCAAGCGGACCGCAAATACCkTCkT     6660 <br />  <br />  <br />            *AspPh LysAlaRisL*LuAr9^rqValAopLyaGluLynGlu rokShrProAaroAl ProA&amp;TrV&amp;lklV aklaknAbSA rCy lynTSTrGlyTrAusLydGlukapGlySerLsLyPhSS <br />                                                                                                                                                                                         7030 <br />  <br />                                                                                                                                    134, <br />            rGlnAlaNetGlnLysThrGluleLyollekpValThrA*SrAnV lGiuklpalclraloly                   cluclrGYIUIAsPL^clyLyrsArgUrThA <br />            GCAGGCC                                                                                 as <br />                                                                                                 ----s                                   c    accAkTGCT <br />                                                                                                                                                s  __ = _ _                              7160 <br />                                                                                                                                                                                         7330 <br />            CAAGCCCGCC ACCC_ _CA _A_?_------_CGCACATAAACCTCTCCAT                                                                                                      TCAOCACTCTT        7480 <br />  <br />                  1351 <br />  <br />                                                                                                   TGT                                            TG=                                    7630 <br />  <br />  <br />  <br />           CACGCCTATTOCCAAACTGACCGAACC                                 ATC                                                                     TGAATC.CCATCGCTGGATCTCAGTGGCTGCAGCTGAG    7760 <br />  <br />  <br />                                                                                                                                                                                         7930 <br />  <br />                                                                                  1520 <br />  <br />              ACGGCAC <br />           GGC^                                 CsaT== SCASG                      SA              ACGG=A^S^_ <br />                                                                                                        ----------GScA                                                                   6060 <br />           GTGATCSSGGGCCCCAATG                                                                                                                                           GCGGA           6230 <br />                                                                                                                                                                                         6360 <br />                S_ATTJIc <br />           CCAAGA GA                                                          A     ,A            TsSc                            CSTTGa          sTcTA                   Ac     CT    6530 <br />                                                                                                                                                                                         660 <br />                                                                                                                                                                                         6630 <br />                                                                                                                                                                                         6960 <br />                                                                                                                                                                                         9130 <br />                                                                                                              eDNA L cDNA G polyA <br />  <br />           AACCAACTGTAATTATATCTGAT            CAST          TTATCS           ACT_                        _                 ATASlAACASTTTCAA KNGATCGAGACAGGCGT                            9290 <br />                                       ATAS=TTSA&quot;C^TCSOCATSSTASOCCTStCCCSACA= = c1 _TCGAAAATTAAAGACAA                                                                                    9430 <br />           AAATGGGCCAACAC   z    FTSCUATTTTCSSSCACA=a c ea c xaas                          _   C ca                                                                                      9560 <br />           GAGAAIZTA=GAT*AAGAA??C 9608 <br />    FIG. 3. Nucleotide sequence predicted amino acid sequence Drosophila abl. Nucleotide residues numbered 5&apos; 3&apos; <br /> direction, + 1 representing mRNA cap site. The nucleotide sequence does include entire introns, positions <br /> and approximate DNA missing indicated arrows. The genomic sequence continuous remaining exons. <br /> The 5&apos; sequence represented cDNA clone (+39) indicated start P1 cDNA. The initiation codon, AUG, located <br /> at nucleotide position +97. The predicted 1,520-residue primary amino acid sequence spans 10 exons printed DNA <br /> sequence indicate exon positions. The extensive homology amino acid sequence mammalian c-abl sequence used locate <br /> several landmark positions sequence. The homologous location gag-abl fusion junction Abelson murine leukemia virus <br /> is shown (V-ABL). The conserved tyrosine kinase essential domain bracketed TPK. It includes conserved 9-amino-acid peptide <br /> (overlined) lysine residue ATP-binding site tyrosine residue (MAJOR) principle target autophosphorylation in <br /> the v-abl gene. In 3&apos; untranslated region, sites poly(A) addition cDNAs L G indicated arrows. Several putative <br /> polyadenylation sites underlined. Putative mRNA degradation signals, AUUUA motifs, indicated bold underline. <br />                                                                                                  847 <br />  848     HENKEMEYER ET AL.                                                                                                 MOL. CELL. BIOL. <br />  <br />  <br />                                                        GCAAATTCGCAATTGCACCTGAGCGGCCACTAGAACAACA                 -262 <br />                                                        AATCAGATAAATCGCAAACTTCCTTTTTCCTCCGTGCGTG                 -222 <br />                                                        TGTACTTCTGTGTGTGCGTGAGTGTCTCCAATCTTTTTTG                 -1 82 <br />                                                        TCTACTCCAAAAACGCAGAAAGAGAAAGAAAAATGTGTGC                 -142 <br />                                        4- Extension    GTGTGTGTGTGTGAAATAAATTAAAGCAAAGCAAAAGGCA                -102 <br />                                                        AAACGGCAAATAATTGAGCAAAAGGCCAAGAGAGAAGAGT                -62 <br />                                                        TAAAGCTGAAGTATATAACAAGAAAAGCAAAGCAAATAAT -22 <br />  <br />                                                        AAGTAGTAGTAGTAAGCGAATAAGCCGTAGCAGCAGGAGC                  19 <br />  <br />                                                        CGAGAGAAGAGAGAGAAAAGTGTACAAGTTGTTGTTGCTG                  59 <br />  <br />                                                        CGCAAGAGCGAAAAACCACCCAACCACCCACTGGCAAATG                +99 <br />  <br />  <br />  <br />  <br />                              A: <br />                               &apos;. <br />  <br />  <br />  <br />  <br />                                     JK.Primer <br />   FIG. 4. Position mRNA cap site. The point abl transcription initiation determined primer extension. A 32P-labeled <br /> synthetic oligonucleotide annealed total embryonic RNA (+) tRNA (-) extended reverse transcriptase. The products were <br /> separated 8% polyacrylamide gel, contained dideoxy sequencing reaction labeled primer size standards. <br /> The sense-strand nucleotide sequence shown. The location synthetic oligonucleotide indicated asterisks. The arrow marks the <br /> position primer extension product defines nucleotide + 1. The translation initiation codon + 97 ATG indicated boldface, <br /> as putative TATA CAAT boxes positions -25 -95, respectively. Two repeating units present 250-bp region upstream <br /> of transcription start site. Stretches alternating purines pyrimidines overlined, AAAGC motif repeated seven times is <br /> underlined. <br /> DNA sequence data sizes derived Si nuclease                  (exons 10.1 10.5 Table 1). Multiple polyadenylation <br /> mapping reported Telford colleagues (49) (Table 1).               sites unprecedented Drosophila genes. Five <br /> The exonic structure derived DNA sequence Fig.               seven polyadenylation sites Drosophila <br /> 3 largely consistent Si nuclease mapping. Probes             tropomyosin gene (4). The abl sequence searched with <br /> containing exons used                  consensus polyadenylation sequence AAUAAA, allow- <br /> protection experiments (49). The inconsistency lies                  ing base changes number different <br /> between exons 6 9 cDNA sequence                    polyadenylation signals used nature (3). After the <br /> codon bias analysis (35) genomic sequence indicate                translation stop codon, consensus AAUAAA <br /> two exons (numbers 7 8) 120 88 bp,                sequences (underlined Fig. 3). The these <br /> Si data predicted single 350-bp exon.                                  close poly(A) addition occurs produce the <br />    The intron DNA sequence (348 bp) falls               second fifth mRNA according data Telford <br /> region Si analysis (49) produces RNAs differing              et al. (49). Sequences differ consensus one <br /> in size approximately 350 bp. This intron absent              nucleotide (underlined Fig. 3) located close ends <br /> all independent cDNA clones isolated spanned               transcripts detected S1 nuclease <br /> this region. However, DNA sequence intron                 mapping. These sequences present tandem arrays of <br /> contains open reading frame frame                copies. In systems, alternative 3&apos; adenyl- <br /> reading frames exons 9 10. Optional splicing              ation signals efficient AAUAAA sequence; <br /> intron rise different-sized mRNAs                  tandem copies compensate lower effi- <br /> detected Si analysis produce protein products             ciency single copy. <br /> differing 116 amino acids.                                               We searched abl sequence consensus <br />    The Si protection experiments Telford et al. (49)              AUUUA, sequence implicated mRNA degra- <br /> indicated different mRNA 3&apos; ends formed                   dation mammalian genes, including proto-onco- <br />  VOL. 8, 1988                                                                       D. MELANOGASTER ABELSON TYROSINE KINASE                    849 <br />  <br />                   TABLE 1. Length exons abl                                   The Drosophila sequence searched se- <br />                         No. bases                      Length exon         quences using GAP program. The amino terminus of <br /> Exon                   protected                      DNA sequence             predicted Drosophila protein similar the <br />                         Si nucleasea                           (bases)              human type lb amino terminus mouse type IV amino <br />                                                                                     terminus. The Drosophila protein contains Gly-Ser-rich <br /> 1                           NDb                            429                      insertions region present mamma- <br /> 2                           ND                              54 <br /> 3                            540                           541                      lian proteins. <br /> 4                            400                           418                         The amino acid sequence similarity low the <br /> 5                            580                           587                      carboxy-terminal portions Drosophila human <br /> 6                            280                           271                      Abelson proteins (amino acids 660 1520 Drosophila <br /> 7                            350                           121                      abO. In region, alignment contains 28 gaps, there <br /> 8                             ?                             89                      16% amino acid identity 28% amino acid similarity. The <br /> 9                           1,650                        1,635                      mouse human amino acid sequences divergent <br /> 10.1                          970                          956 (ATTAAA)C            region, 140 amino acids well <br /> 10.2                        1,190                        1,180 (AATAAA)C            conserved (45). A search National Biomedical Re- <br /> 10.3                        1,340                        1,310 (GATAAA)C            search Foundation protein data base conducted, no <br /> 10.4                        1,740                        1,735 (CATAAA)d <br />                                                          1,742 (AAT7AA)C            significant sequence similarities other <br /> 10.5                        2,190                        2,104 (AATAAA)C            genes data base carboxy domains the <br />   From reference 49. <br />                                                                                     Drosophila mammalian abl proteins. <br />   b ND, Not determined.                                                                Tyrosine kinase activity. The extensive sequence similarity <br />     All exons 10 begin splice acceptor junction. The different sizes    Drosophila Abelson protein human and <br /> for 10.1 10.5 differences 3&apos; ends exons. The sizes      murine c-abl proteins suggests Drosophila abl <br /> shown nearest polyadenylation consensus sequence (shown               protein tyrosine kinase. As effort raise <br /> parentheses).                                                                       antisera Drosophila protein, 3-galactosidase-abl fu- <br />   d The length exon 10.4 set position poly(A) tails found <br /> on cDNAs L G.                                                                   sion proteins expressed E. coli. Phosphor- <br />                                                                                     ylation proteins measured using anti-PTyr anti- <br />                                                                                     body kindly provided J. Y. J. Wang (University of <br /> genes (43). A total 16 representatives sequence                           California, San Diego) (52). E. coli does contain detect- <br /> were found; 10 copies detected intronic sequences                           able PTyr anti-PTyr, E. coli expressing kinase <br /> and 6 copies 3&apos; untranslated regions. The                         essential domain v-abl contains high levels PTyr (19). <br /> noted Fig. 3 bold underline.                                                   Two regions Drosophila abl gene cloned into <br />    Alignment Drosophia human Abelson genes. The                              pUR series expression vectors (Fig. 6). pURABLkin <br /> Genbank data base searched Drosophila abl                              contains tyrosine kinase-homologous region SH2 <br /> amino acid sequence using FASTP (24) WordSearch                               region, plus flanking sequences. pURABLcarb contains a <br /> (8; University Wisconsin Genetics Computer Group). The                           portion gene nonconserved carboxy-terminal <br /> most similar sequences human murine c-abl                          region. When immunoblots lysates induced cells <br /> proteins. Alignment predicted Drosophila amino acid                          containing pUR290, pURABLkin, pURABLcarb were <br /> sequence human sequence performed                             probed high-affinity anti-PTyr, proteins either <br /> different programs: FASTP (24), homology matrix (34),                           pUR290- pURABLcarb-containing cells PTyr <br /> GAP (29; University Wisconsin Genetics Computer                                  residues. In contrast, peptides pURABLkin cell <br /> Group). The alignments similar respects.                          lysates reacted anti-PTyr antibody (Fig. 7). The <br />    The alignment generated GAP shown Fig. 5. The                           major phosphorylated protein pURABLkin fusion <br /> program accounted conservative amino acid changes                               protein. Most protein bands seen blot are <br /> (12). Overall, Drosophila human abl genes 62%                          degradation products fusion protein. We fully <br /> amino acid sequence similarity optimized alignment                           confident bacterial proteins phosphorylated. <br /> (including identical conservative amino acids). The <br /> location tyrosine kinase domain abl proteins                                             DISCUSSION <br /> in amino-terminal half protein. This organization <br /> contrasts src cytoplasmic tyro-                           A detailed molecular analysis Drosophila abl gene <br /> sine kinases, kinase domain carboxy                          initiated determine extent similarity be- <br /> end protein. In region essential protein tyrosine                    tween Drosophila abl sequence mammalian abl <br /> kinase activity, sequences 87% similar 77%                              sequences, map entire abl transcriptional <span id='am-9' about='Thesaurus:Unit' typeof='owl:Thing'>unit</span>, to <br /> identical. The boundaries kinase essential region                        determine Drosophila abl protein actually func- <br /> derived alignments vertebrate tyrosine kinase do-                           tions tyrosine kinase. The Drosophila abl amino acid <br /> mains (17). To amino-terminal tyrosine kinase                       sequence similar mammalian c-abl sequence <br /> domain second conserved region, SH2 (src homology                          gene. The homology Drosoph- <br /> no. 2) domain. This 100-amino-acid domain                               ila human c-abl sequences extends the <br /> cytoplasmic tyrosine protein kinases trans-                          regions previously reported (15). More importantly, the <br /> membrane receptor tyrosine kinases (38). The Drosophila                             homologous region extends portion abl <br /> and human abl sequences 86% similar 78% identical                           protein essential tyrosine kinase activity. The <br /> in SH2 region. The strong similarity Dro-                           tyrosine kinase essential domain deduced align- <br /> sophila human Abelson proteins begins 73 amino acids                            ments tyrosine kinases (38) deletion analysis <br /> before SH2 region extends 24 amino acids                             abl gene measurement tyrosine kinase activity <br /> the tyrosine kinase essential domain.                                               (32). The similarity Drosophila human <br />    Four different amino termini detected                          abl amino acid sequences 75% Drosophila amino <br /> mouse c-abl gene human c-abl gene (1, 45).                          acids 187 656, 469-amino-acid domain. When conserv- <br />  850            HENKEMEYER ET AL.                                                                                           MOL. CELL. BIOL. <br />  <br />        1       W&#194;&#167;AQQGKDRGRHSGGGGSGAPVSCIGLSSSPVASVSPHCISSSSGVSSAPLGGSTLRGSRIKSSSSGVASGSGSGGGSGSGLSQRSGGHXDARCNP                           100 <br />                                                                                                                                           100 <br />            11            1 <br />  <br />        1 MGQQPGKVLGDQR .........................................................................                                       P 15 <br />    101                        SRPLPHIPAGSTRPLFNRIAELQQHQQDSGGLGLQGSSLGGGHSSTTSVFESAHR&quot;SENLLG 200 <br />            TVGLNIFT2HNGT0HSSFRG0PGKY0MAT <br />             :&apos;I lIi II11 : :::I <br />                            11                                               :1I11111111111 <br />       16 SLPALHFIKGAGKXESSRHGGP.HCWFVEQALQRPVASDFEPQG ...................................... LSEAARINSKENLLA.G 75 <br />  <br />    201 PEEDDPQLFVALYDFQAG     QLSLKGEQVRILSYNKSGECEAHSDSGNVGWPSNYVTPLNSLEKHSWYHGPISRNAAEYLLSSGINGSFLVRESES 300 <br />                                                 111111: <br />                1 1:11 11111111 1-1:1 11: 111 :1:1:11      1 IIIII11:II:IIIIIIIIIIII:IIIIIII 111111I11111111&apos;1 <br />       76 PSENDPNIFVALYDFVASGDNTLSITKGEKLRVlGYNHNGENCAQTKNQ.GWVPSNYITPVNSLEKHSWYHGPVSRNAAEYPLSSGINGSFLVRESES 174 <br />  <br />    301 SPG4RSISLRYEGRVYHYRISEDP0EAKFNTLAELVHHHSVPHEGHGLITPLLYPAPKQNKPTVFPLSPEPDENEICRTDIMMKHKLGGGQYG <br />                                                                                                   400 <br />            II:II1IIIIIIII111II1    III::I 1I:IIII1I111111      : 1111 1 11111 11111: :11 1 11:&apos;1111 lIlII1 <br />    175     SPSQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTL&amp;ELVHHHSTV..ADGLITTLHYPAPKRNKPTVYGVSPNYDKnEMERTDITMKHKLGGGQYG 272 <br />    401 EVYEAVW     RYGNTVAVKTLKEDTMALKDFLEEAIMXEMZHPNLVQLIGVCTREPPFYIITEFMSHGNLLDFLRSAGRETLDAVALLYMATQIASGMSYL                            500 <br />                        IIIII11111&apos;:I <br />                    11:1111:! <br />            &apos;111111111  11111               III:IIIIIIII:IIIIIIIiIII          11&apos;111:11 i::11 11111111 1:1 11 <br />    273 EVYE           IKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLIGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYN&amp;TQISSAMEYL 372 <br />    501     ESRNYIHRDIAARNCLVGDNKLVKVADFGLARLMRDDTYTAHAGAKFPIKTAPEGLAYNKFSTKSDVWAFGVLLWEIATYGMSPYPAIDLTDVYHKLDK                            600 <br />            I :I:IIIIIIII1I111:I 111111111 111 :I11111111111111111:1111111 1111111111111I11111111:11 :11 1:1 <br />    373     EKKNFIHRDLI&amp;RNCLVGENHLVKVADFGLSRLMTGDTYTAHAG&amp;KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDRSQVYELLEK                           472 <br />    601 GYRMERPPGCPPEVYDIMR4CNQWDATDRPTFKSIHHALEHMFQESSITEAVEKQLNATSASSSAPSTSGVATGGGATTTTAASGCASSSSATASLSL 700 <br />        :1I1II1I11I1 I I1:IIII&apos;I::II1      1 1: 1:1111111 1: III:I1&apos;             I ::      II            I: <br />    473 DYRMKRPEGCPEKVYEIMRACWQWNPSDRPSFAEIHQAFETHFQESSISDEVEKELGKQGVRG ..... AVSTLLQAPELPTKTRTSRRAAEHRDTTDVPE 567 <br />    701 TPQ MGLPGGQALTPNAHHNDPHQQQASTPMSETGSTSTKLSTFSSQGKGNVQMRRTTNKQGKQAPAPPKRTSLLSSSRDSTYREEDPANARCNFIDD 800 <br />         1:    11   :::I                          :1 ::II1:             11I11 111              1 :11 1     1 <br />    568 MPH ..SKGQGESDPLDHEPAVSPLLPRKERGPPEGGLNEDERL .. LPKDKKTNL.FSALIKKKKKTAPTPPKAS ........ SSFREMDGQPERRG.... 650 <br />  <br />    801     LSTNGL&amp;RDINSLTQRYDS.ETDPAADPDTDATGDSLEQSLSQVIAPVTNKMQHSLHSGGGGGGIGPRSSQQHSSFKRPTGTPVMGNRGLETRQSKRSQ                            899 <br />              &apos;: I I      :   :I         :: :                    : :1I1: 1 : I    I :I <br />    651 .AGEEEGRDISNGALAFTPLDTADPAKSPKPSNGAGVPNG ............... ALRESGGSGFRSPHLWKSSTL .TSSR 715 <br />  <br />   900      LHSQAPGPGPPSTQPHHGNNGVVTSAHPITVGALDVHNVKQVVNRYGTLPKGARGAYLDSLEDSSEAAPALPATAPSLPPA. .NGHATPPAARLNPKAS                           997 <br />            I            I I         :1    :1              1:    1 111::                            11: : <br />                                                                                                      :1     11:      11 <br />   716 LITGEEEGGGSSSKRFLRSCSVSCVPH .......... GAKDTEWRSVTLPRD ................... LQSTGRQFDSSTFGGHKSEKPALPRKKAG 786 <br />  <br />   998 PIPPQQMRSNSSGGYSLNN        KLQRHRTTTEGT HTFSSRAGGSSSSPXRSASGVASGVQPALANLEFPPPPLDLPPPPEEFEGGPPPPPPAP 1097 <br />           :1: 1:                  ::::1I:I <br />                                          :                                II             I: :II 1: 1:: 1:&apos;1: <br />   787 ENRSDQVTRCTVTPPPRLVKKNWEEAADEVFKD ............ INESSPGSSPPNLTPKPLRRQVTVA ........ PASGLPHKEEAWKGSALGTPAAA 866 <br />  <br />  1098 ESAVQAI19HLHAQLPNNGNISNGNGTNNNDSSHNDVSNIAPSVEASSRFG.VSLRKREPSTDSCSSLGSPPEDLKEKLITEIKAAGKDTAPASHLANG <br />                                                                                                       1196 <br />         I               : :   11::~~~~~~~~I <br />                                          1     I1 1      :1 1 1         I             11:11    :: I I <br />   867 EPVTPT ......    VRAGSGAPRGTSXGPAESRKSSESPGRDKGKLSKLKPAPPPPPAASAG .KAGGKPSQRPGQEA&amp;G 942 <br />  1197      SGIAVVDPVSLLVTELESNNLPKiPPPQQQQKLTNGNSTGSGFKAQLKKVEP!LSPMPKRTANTIIDFKAHLRRVDKEKEPATP.APAPATVAVANNA                             1295 <br />                  ::           ~~~~I <br />                                 I: :1    :1I              1 1:1 :        11                                   I:11 :11:               I <br />       ....... TSLVDAVNSDAAKPSQP. <br />   943 EAVLGAKTA                                          GEGLKKPVLPATPKPQPA .................                KPSGTPISPAPVPLSTLPSA 1007 <br />  <br />  1296 NCNTTGTINRKEDGSKKSwIQKTEIKIDVTNSNDAGAAGEGDLGKRSTDDEEQSHTEGLGSGGGSADMTQSLYEQKPQIQQKPAVPHPTKLT 1395 <br />          : I     :: I    ::    :: 1      1: 11    1:                           1 1: 1: <br />  1008 SSALAG    DQPSSTAFIPLISTRVSLRKTRQPPEPASGAITKGW ........................ LSTELC .................... 1058 <br />                       ..... <br />  <br />  <br />  <br />  <br />  1396 IYATPIA1TEPASSASST4ISESILELVGLEGSLKHPVIAGS9W0LSDILHNSCVIFAENGMPPHSKFQFELVRVEQSQHLR               1490 <br />                    1 1: 11:   1:                   1:: 1: 1:1           ::     I1I11: ::1       1 <br />  1059 ...........LAISGNSEQMSHSAV ................ LEAGKNLYTFCVSYV .... DSIQQNRNKAFREAINKLENNLRELQICPAS 1121 <br />  1491 .SAGSKNVQDNERLVAEVGQSLRQISNALNR 1520 <br />                 :I      11    :1:   1:::11:: I <br />  1122 AGSGPAATQDFSKLLS.... SVKEISDIVQR 1148 <br />   FIG. 5. Comparison predicted amino acid sequences Drosophila human abl proteins. The Drosophila abl amino acid <br /> sequence (top line) aligned human c-abl amino acid sequence (lower line) program GAP (University Wisconsin <br /> Genetics Computer Group). The program set gap weight 3.75 length weight 0. Conservative amino acid changes were <br /> scored using modified Dayhoff table amino acid substitutions (12). Identical amino acids indicated solid bar, conservative <br /> amino acid changes shown dots. The type lb human c-abl amino terminus (45) shown gave better alignment with <br /> the Drosophila sequence did alternate human c-abl amino terminus. The SH2 region cytoplasmic tyrosine kinases (38) aligns <br /> with amino acids 260 359 Drosophila abl sequence. The tyrosine kinase essential domain (17) aligns amino acids 381 632 of <br /> the Drosophila abl sequence. <br />  VOL. 8, 1988                                                           D. MELANOGASTER ABELSON TYROSINE KINASE                              851 <br />  <br />                                                             I Kbp <br />                                                         a <br />                                                                                                                              -2 <br />                                                                                        c                                            a~ <br />                   SH2      TPK                                                                                                         l <br />                                                                                         v <br />  aml I                 _                                                       0)      CO                      0)               I <br />  cDNA <br />  <br />                 Poti     ,0 <br />                                      II <br />                                  Pvull     Pstl   v~Pstl                       gr                             CMJ <br />                                                                                                                   cc <br />                                                                                                                          M <br />                                                                                                                                    i <br />                         /stl                                                                                       n.L       nCL       IC <br />                        Pvull                      Pot <br />  <br />  <br />          Pstl              (Pvull)                 PotI         neti                                  lB OKd <br />  <br />  <br />                                                                                                        116 <br />  <br />  <br />                                                                                                       &apos; 84 <br />  <br />  <br />  <br />                                                                                                         58 <br />  <br />  <br />                                                                                                         48.5 <br />  <br />                                                                                  Ponseau S                         anti-PTyr <br />                                                                           FIG. 7. Tyrosine kinase activity abl kinase domain ex- <br />                                                                         pressed E. coli. Immunoblot analysis performed ly- <br />                                                                         sates cells containing expression plasmids pUR290, <br />                                                                         pURABLcarb, pURABLkin. Similar amounts protein were <br />                                                                         loaded lane, indicated staining proteins the <br />                                                                         nitrocellulose filter Ponseau S, shown left panel. The <br />                                                                         major proteins lanes pUR290, pURABLcarb, pURABLkin <br />                                                                         ,-galactosidase (116 kilodaltons), pURABLcarb fusion pro- <br />   FIG. 6. Construction abl expression plasmids pURABLkin             tein (155 kilodaltons), pURABLkin fusion protein (170 <br /> and pURABLcarb. The abl cDNA shown line                 kilodaltons), respectively. The right panel shows immunoblot of <br />                                                                         similarly prepared nitrocellulose blot anti-PTyr antibody. <br /> composite overlapping abl cDNA clones 10 exons        Note proteins pURABLkin lane detected. The <br /> indicated 10 boxes. The positions putative initiation     major phosphorylated protein pURABLkin fusion protein, <br /> and termination codons indicated cDNA. The cDNA           peptides react anti-PTyr <br /> fragment used constructing pURABLkin contains SH2 re-            antibody degradation products fusion protein. Kd, Kilo- <br /> gion (conserved cytoplasmic tyrosine kinases) tyro-       daltons. <br /> sine kinase essential domain (TPK); cDNA fragment used in <br /> pURABLcarb derived carboxy-terminal domain of <br /> unknown function. Restriction sites used construction     kinase providing hydrophobic anchor membranes <br /> plasmids shown; sites destroyed cloning procedure        (54). <br /> shown parentheses. The abl sequences expressed fusions           We evidence multiple amino termini has <br /> with lacZ using inducible promoter Lac operon. Kbp,       reported mouse human abl genes (1, 45). <br /> Kilobase pairs.                                                         However, ruled existence other <br />                                                                         amino termini Drosophila abl gene. In primer <br />                                                                         extension experiment used map site transcriptional <br /> ative amino acids included calculations,            initiation, hybridized oligonucleotide primer exon 1 <br /> similarity 85% 469-amino-acid domain. In                detected alternative first <br /> addition sequences essential tyrosine kinase activ-          exons. Further isolation cDNA clones Si <br /> ity, large region homology spans sequence               nuclease mapping additional primer extension experi- <br /> conserved cytoplasmic tyrosine kinases, SH2              ments used determine exons and <br /> domain (38).                                                            amino termini exist Drosophila abl gene. <br />    The amino acid sequence homology Drosoph-                   The carboxy half abl protein conserved <br /> ila abl gene human abl gene begins 12              D. melanogaster mammals. The function of <br /> amino acids proteins. This initial homology               domain protein known. It required for <br /> soon interrupted glycine- serine-rich insertions          v-abl-induced transformation fibroblasts lymphoid cells <br /> the Drosophila sequence. The amino termini align              (33). In Rat-1 cells, sequences carboxy <br /> the Drosophila sequence compared type lb                    domain v-abl toxic cells spontaneous <br /> human type IV murine amino termini. The specific                 deletions region selected (56). Although the <br /> function, any, mammalian amino termini               sequence homology poor, similarities <br /> known. They provide N-terminal glycine, does               carboxy portions Drosophila mam- <br /> Drosophila sequence, site myristylation,            malian abl genes. The sizes protein domains carboxy <br /> as case v-src v-abl proteins. Myristylation           kinase domains similar: 864 amino acids D. <br /> could affect intracellular localization abl tyrosine         melanogaster 620 amino acids humans. Within the <br />  852     HENKEMEYER ET AL.                                                                                               MOL. CELL. BIOL. <br />  <br /> carboxy domain human c-abl sequence, region                    sources enriched ribonuclease. Biochemistry 18: <br /> between amino acids 800 1000 17.5% proline (45). The                5294-5299. <br /> Drosophila sequence 8% proline overall, region              6. Dale, R. M. K., B. A. McClure, J. P. Houchins. 1985. A <br /> between amino acids 950 1150 14% proline. This region               rapid single-stranded cloning strategy producing sequential <br />                                                                           series overlapping clones use DNA sequencing: appli- <br /> of highest proline content approximately aligns                  cation sequencing corn mitochondrial 18 S rDNA. Plas- <br /> proline-rich region human sequence.                                mid 13:31-40. <br />    By expressing kinase essential domain bacteria,           7. Davis, R. L., J. B. Konopka, 0. N. Witte. 1985. Activation <br /> showed homology mammalian abl                    c-abl oncogene viral transduction chromosomal <br /> the Drosophila abl proteins extends enzymatic                    translocation generates altered c-abl proteins similar in <br /> activity. When domain expressed E. coli, exten-               vitro kinase properties. Mol. Cell. Biol. 5:204-213. <br /> sive phosphorylation proteins tyrosine residues              8. Devereux, J., P. Haeberli, 0. Smithies. 1984. A comprehen- <br /> observed. A similar result observed kinase              sive set sequence analysis programs VAX. Nucleic <br /> portion v-abl protein (19). Two examples suggest              Acids Res. 12:387-395. <br />                                                                        9. Erikson, J., C. A. Griffin, A. ar-Rushdi, M. Valtieri, J. Hoxie, J. <br /> the activity bacteria good indication normal               Finan, B. S. Emanuel, G. Rovera, P. C. Nowell, C. M. <br /> activity proteins. Deletions v-abl protein            Croce. 1986. Heterogeneity chromosome 22 breakpoint in <br /> abolish kinase activity E. coli abolish transform-            Philadelphia-positive (Phi) acute lymphocytic leukemia. Proc. <br /> ing activity v-abl protein NIH 3T3 cells (32).                  Natl. Acad. Sci. USA 83:1807-1811. <br /> Temperature-sensitive mutations kinase activity             10. Garoff, H., W. Ansorge. 1981. Improvements DNA <br /> v-abl expressed bacteria temperature sensitive            sequencing gels. Anal. Biochem. 115:450-457. <br /> focus-forming ability mammalian cells (19).                        11. Gregory, R. J., K. L. Kammermeyer, W. S. Vincent Ill, and <br />    This Drosophila sequence specifically               S. G. Wadsworth. 1987. Primary sequence developmental <br /> associated tyrosine kinase activity. Previous indica-                expression novel Drosophila melanogaster src gene. Mol. <br />                                                                           Cell. Biol. 7:2119-2127. <br /> tions tyrosine kinase activity D. melanogaster include          12. Gribskov, M., R. R. Burgess. 1986. Sigma factors E. <br /> phosphorylation tumor-bearing rabbit antisera tyrosine              coli, B. subtilis, phage SPOl, phage T4 homologous <br /> residues proteins Drosophila embryos (47)                     proteins. Nucleic Acids Res. 14:6745-6763. <br /> detection PTyr Drosophila embryos anti-PTyr                13. Hafen, E., K. Basler, J.-E. Edstroem, G. M. Rubin. 1987. <br /> antibodies (48).                                                          Sevenless, cell-specific homeotic gene Drosophila, encodes <br />    Protein kinases regulate broad variety biochemical                putative transmembrane receptor tyrosine kinase <br /> processes eucaryotic cells (16). The involvement tyro-              domain. Science 236:55-63. <br /> sine protein kinase activity transforming oncoproteins         13a.Henkemeyer, M. J., F. B. Gertler, W. Goodman, F. M. <br /> growth factor receptors leads suspect                     Hoffmann. 1987. The Drosophila Abelsen proto-oncogene ho- <br />                                                                           molog: identification mutant alleles pleiotropic <br /> tyrosine kinases modulate processes critical regulation            effects late development. Cell 51:821-828. <br /> of cell growth differentiation both. To understand         14. Hoffman-Falk, H., P. Einat, B.-Z. Shilo, F. M. Hoffmann. <br /> these processes individual tyrosine kinases                   1983. Drosophila melanogaster DNA clones homologous to <br /> modulate them, begun genetic analysis                    vertebrate oncogenes: evidence common ancestor the <br /> Drosophila tyrosine kinases. We shown Dro-                  src abl cellular genes. Cell 32:589-598. <br /> sophila abl gene required proper development               15. Hoffmann, F. M., L. D. Fresco, H. Hoffman-Falk, B.-Z. <br /> viability D. melanogaster (13a). The results presented                 Shilo. 1983. Nucleotide sequences Drosophila src abl <br /> here Drosophila abl gene tyrosine kinase               homologs: conservation variability src family onco- <br /> by amino acid sequence similarity biochemical                    genes. Cell 35:393-401. <br /> activity.                                                             16. Hunter, T. 1987. A thousand protein kinases. Cell <br />                                                                           50:823-829. <br />                                                                       17. Hunter, T., J. A. Cooper. 1985. Protein-tyrosine kinases. <br />                       ACKNOWLEDGMENTS                                     Annu. Rev. Biochem. 54:897-930. <br />   We dedicate research memory Christine A. Phelan. We      18. Katzen, A. L., T. B. Kornberg, J. M. Bishop. 1985. Isolation <br /> thank J. Y. J. Wang (University California, San Diego)             proto-oncogene c-myb D. melanogaster. Cell <br /> providing anti-PTyr antibodies.                                       41:449-456. <br />   This work funded American Cancer Society grant NP483         19. Kipreos, E. T., G. J. Lee, J. Y. J. Wang. 1987. Isolation of <br /> to F.M.H., Cancer Center support grant CA07175 National          temperature-sensitive tyrosine kinase mutants v-abl onco- <br /> Cancer Institute McArdle Laboratory, predoctoral train-        gene screening antibodies phosphotyrosine. Proc. <br /> ing grant CA09135 National Cancer Institute support       Natl. Acad. Sci. USA 84:1345-1349. <br /> M.J.H. R.L.B.                                                     20. Laemmli, U. K. 1970. Cleavage structural proteins the <br />                                                                           assembly head bacteriophage T4. Nature (London) <br />                        LITERATURE CITED                                   227:680-685. <br />  1. Ben-Neriah, Y., A. Bernards, M. Paskind, G. Q. Daley, D.      21. Laughon, A., M. P. Scott. 1984. Sequence Drosophila <br />     Baltimore. 1986. Alternative 5&apos; exons c-abl mRNA. Cell 44:         segmentation gene: protein structure homology DNA- <br />     577-586.                                                              binding proteins. Nature (London) 310:25-31. <br />  2. Biggin, M. D., T. J. Gibson, G. F. Hong. 1983. Buffer         22. Lev, Z., N. Leibovitz, 0. Segev, B.-Z. Shilo. 1984. Expres- <br />     gradient gels &quot;S <span id='am-5' about='rdfs:label' typeof='owl:Thing'>label</span> aid rapid DNA sequence            sion src abl cellular oncogenes development of <br />     determination. Proc. Natl. Acad. Sci. USA 80:3963-3%5.                Drosophila melanogaster. Mol. Cell. Biol. 4:982-984. <br />  3. Birnsteil, M. L., M. Busslinger, K. Strub. 1985. Transcrip-   23. Levinson, A., D. Silver, B. Seed. 1984. Minimal size plas- <br />     tion termination 3&apos; processing: end site! Cell          mids containing M13 origin production single-stranded <br />     41:349-359.                                                           transducing particles. J. Mol. Appl. Genet. 2:507-517. <br />  4. Boardman, M., G. S. Basi, R. V. Storti. 1985. Multiple        24. Lipman, D. J., W. R. Pearson. 1985. Rapid sensitive <br />     polyadenylation sites Drosophila tropomyosin gene            protein similarity searches. Science 227:1435-1441. <br />     used generate functional mRNAs. Nucleic Acids Res.             25. Livneh, E., L. Glazer, D. Segal, J. Schlessinger, B.-Z. Shio. <br />     13:1763-1776.                                                          1985. The Drosophila EGF receptor gene homolog: conserva- <br />  5. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, W. J.           tion hormone binding kinase domains. Cell <br />     Rutter. 1979. Isolation biologically active ribonucleic acid       40:599-607. <br />  VOL. 8, 1988                                                            D. MELANOGASTER ABELSON TYROSINE KINASE                              853 <br />  <br /> 26. Maniatis, T., E. F. Fritsch, J. Sambrook. 1982. Molecular              Drosophila melanogaster ras transcripts development. <br />     cloning: laboratory manual. Cold Spring Harbor Laboratory,               Mol. Cell. Biol. 6:2241-2248. <br />     Cold Spring Harbor, N.Y.                                             43.   Shaw, G., R. Kamen. 1986. A conserved AU sequence from <br /> 27. McKeown, M., J. M. Belote, B. S. Baker. 1987. A molecular              3&apos; untranslated region GM-CSF mRNA mediates selec- <br />     analysis transformer, gene Drosophila melanogaster            tive mRNA degradation. Cell 46:659-667. <br />     controls female sexual differentiation. Cell 48:489-499.             44.   Shilo, B.-Z. 1987. Proto-oncogenes Drosophila melanogaster. <br /> 28. Mills, D. R., F. R. Kramer. 1979. Structure-independent                Trends Genet. 3:69-72. <br />     nucleotide sequence analysis. Proc. Natl. Acad. Sci. USA             45.   Shtivelman, E., B. Lifshitz, R. P. Gale, B. A. Roe, E. <br />     76:2232-2235.                                                              Canaani. 1986. Alternative splicing RNAs transcribed from <br /> 29. Needleman, S. B., C. D. Wunsch. 1970. A general method                 human abl gene ber-abl fused gene. Cell <br />     applicable search similarities amino acid                47:277-284. <br />     sequence proteins. J. Mol. Biol. 48:443-453.                  46.   Simon, M. A., B. Drees, T. Kornberg, J. M. Bishop. 1985. <br /> 30. Neuman-Silberberg, F. S., E. Schejter, F. M. Hoffmann,                 The nucleotide sequence tissue-specific expression of <br />     B.-Z. Shilo. 1984. The Drosophila ras oncogenes: structure             Drosophila c-src. Cell 42:831-840. <br />     nucleotide sequence. Cell 37:1027-1033.                              47.   Simon, M. A., T. B. Kornberg, J. M. Bishop. 1983. Three <br /> 31. Poole, S. J., L. M. Kauvar, B. Drees, T. Kornberg. 1985.               loci related src oncogene tyrosine-specific protein <br />     The engrailed locus Drosophila: structure analysis                kinase activity Drosophila. Nature (London) 302:837-839. <br />     embryonic transcript. Cell 40:37-43.                                 48.   Sullivan, W. 1987. Independence offushi tarazu expression with <br /> 32. Prywes, R., J. G. Foulkes, D. Baltimore. 1985. The minimal             respect cellular density Drosophila embryos. Nature <br />     transforming region v-abl segment encoding protein-              (London) 327:164-167. <br />     tyrosine kinase. J. Virol. 54:114-122.                               49.   Telford, J., J. Burckhardt, B. Butler, V. Pirrotta. 1985. <br /> 33. Prywes, R., J. G. Foulkes, N. Rosenberg, D. Baltimore.                 Alternative processing developmental control tran- <br />     1983. Sequences A-MuLV protein needed fibroblast                scripts Drosophila abl oncogene homologue. EMBO J. <br />     lymphoid cell transformation. Cell 34:569-579.                         4:2609-2615. <br /> 34. Pustell, J., F. C. Kafatos. 1982. A high speed, high capacity    50.   Towbin, H., T. Staehelin, J. Gordon. 1979. Electrophoretic <br />     homology matrix: zooming SV40 polyoma. Nucleic                 transfer proteins polyacrylamide gels nitrocellulose <br />     Acids Res. 10:4765-4782.                                                   sheets: procedure applications. Proc. Natl. Acad. Sci. <br /> 35. Pustell, J., F. C. Kafatos. 1984. A convenient adaptable           USA 76:43504354. <br />     package programs DNA protein sequence            51.    lrich, A., J. R. Beil, E. Y. Chen, R. Herrera, L. M. Petruzzelli, <br />     management, analysis, homology determination. Nucleic                  T. J. Dull, A. Gray, L. Coussens, Y.-C. Liao, M. Tsubokawa, A. <br />     Acids Res. 12:643-655.                                                     Mason, P. H. Seeburg, C. Grunfeld, 0. M. Rosen, J. Rama- <br />                                                                                chandran. 1985. Human insuli <br /> </body></html>